Chief Science Officer
SensoPath Technologies, Inc
Bozeman
USA
Research interests
- Two-photon PDT of recurring refractory H&N tumors
- Targeted PDT for cancer treatment
- Image-guided PDT
- treatment of tumors harboring Kras and/or TP53 mutations